|
|
Volumn 16, Issue 11, 1998, Pages 3481-3482
|
|
Paclitaxel and cardiotoxicity: Editorial
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
DOXORUBICIN;
MONOCLONAL ANTIBODY;
PACLITAXEL;
TRASTUZUMAB;
UNCLASSIFIED DRUG;
ANTINEOPLASTIC AGENT;
BREAST CANCER;
CARDIOTOXICITY;
CLINICAL TRIAL;
CONGESTIVE HEART FAILURE;
DOSE RESPONSE;
EDITORIAL;
GYNECOLOGIC CANCER;
HUMAN;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
CHEMICALLY INDUCED DISORDER;
HEART DISEASE;
NOTE;
RISK FACTOR;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
DOXORUBICIN;
HEART DISEASES;
HEART FAILURE, CONGESTIVE;
HUMANS;
PACLITAXEL;
RISK FACTORS;
|
|
EID: 0032209332
PISSN: 0732183X
EISSN: None
Source Type: Journal
DOI: 10.1200/JCO.1998.16.11.3481 Document Type: Editorial |
|
Times cited : (20)
|
|
References (11)
|
